1. Home
  2. MGRC vs NRIX Comparison

MGRC vs NRIX Comparison

Compare MGRC & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McGrath RentCorp

MGRC

McGrath RentCorp

HOLD

Current Price

$113.39

Market Cap

2.9B

ML Signal

HOLD

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$25.77

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGRC
NRIX
Founded
1979
2009
Country
United States
United States
Employees
N/A
357
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.6B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
MGRC
NRIX
Price
$113.39
$25.77
Analyst Decision
Buy
Strong Buy
Analyst Count
2
12
Target Price
$141.50
$30.50
AVG Volume (30 Days)
104.6K
1.1M
Earning Date
04-29-2026
04-08-2026
Dividend Yield
1.67%
N/A
EPS Growth
N/A
N/A
EPS
2.47
N/A
Revenue
$944,235,000.00
$76,987,000.00
Revenue This Year
$4.69
N/A
Revenue Next Year
$4.81
$48.05
P/E Ratio
$45.25
N/A
Revenue Growth
3.65
99.31
52 Week Low
$94.99
$8.20
52 Week High
$125.83
$28.23

Technical Indicators

Market Signals
Indicator
MGRC
NRIX
Relative Strength Index (RSI) 53.47 50.27
Support Level $112.11 $24.61
Resistance Level $116.87 $28.23
Average True Range (ATR) 1.82 1.02
MACD 0.45 -0.12
Stochastic Oscillator 99.52 49.72

Price Performance

Historical Comparison
MGRC
NRIX

About MGRC McGrath RentCorp

McGrath RentCorp is a diversified business-to-business rental company with three rental divisions: relocatable modular buildings, portable storage containers, and electronic test equipment. It comprises four reportable business segments, namely the Modular Building segment (Mobile Modular), which generates maximum revenue; the Portable Storage segment (Portable Storage); the Electronic Test Equipment segment (TRS-RenTelco); and its classroom manufacturing business (Enviroplex), which sells modular buildings used as classrooms in California. The company generates its revenues mainly from the rental of its equipment under operating leases, with sales of equipment occurring in the normal course of business.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: